Yahoo Search Busca da Web

Resultado da Busca

  1. 9 de out. de 2022 · A balance among benefits, harms, and cost-effectiveness of various colorectal cancer screening tests is important because colonoscopy is more invasive and burdensome for patients than...

  2. 27 de out. de 2022 · In intention-to-screen analyses, the risk of colorectal cancer at 10 years was 0.98% in the invited group and 1.20% in the usual-care group, a risk reduction of 18% (risk ratio, 0.82; 95% confidence interval [CI], 0.70 to 0.93).

  3. 15 de ago. de 2020 · As a clinician, based on our experience, colonoscopy can detect cancer early and have a positive effect on the prognosis of patients, although early colonoscopy is more expensive. However, its cost is lower in the long run, compared with the treatment of advanced cancer.

    • Jiaxin Zhang, Guang Chen, Zhiguo Li, Peng Zhang, Xiaoke Li, Da'nan Gan, Xu Cao, Hongbo Du, Jiaying Z...
    • 10.7150/jca.46661
    • 2020
    • J Cancer. 2020; 11(20): 5953-5970.
  4. screening colonoscopy reduced the risk of colorectal cancer over 10 years; 455 persons needed to be invited to undergo screening to prevent one case of colorectal cancer.

  5. 1 de out. de 2023 · Current guidelines recommend colonoscopy as a valid screening technique in the setting of average-risk population for colorectal cancer (CRC), non-syndromic familial CRC, hereditary CRC syndromes and patients with long-standing inflammatory bowel disease with colon involvement.

  6. 18 de mar. de 2021 · Abstract. Background. It remains unknown whether the benefit of colonoscopy screening against colorectal cancer (CRC) and the optimal age to start screening differ by CRC risk profile. Methods.

  7. 9 de out. de 2022 · Randomized trial data are needed to quantify the effect of colonoscopy screening on the risks of colorectal cancer and related death. New research findings are summarized in a short video.

  1. Anúncio

    relacionado a: effects of colonoscopy on cancer
  2. Frequent Questions For Physicians About Colorectal Cancer. HER2+ mCRC Treatment Option. Learn About An FDA-Approved Treatment Option For HER2+ Metastatic Colorectal Cancer.